VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $58,581,000 | -1.0% | 2,300,000 | 0.0% | 0.84% | -15.0% |
| Q1 2022 | $59,156,000 | -25.1% | 2,300,000 | 0.0% | 0.98% | -31.5% |
| Q4 2021 | $78,959,000 | -49.2% | 2,300,000 | -35.6% | 1.44% | -53.4% |
| Q3 2021 | $155,473,000 | -13.5% | 3,572,438 | -6.0% | 3.08% | -6.2% |
| Q2 2021 | $179,664,000 | -7.8% | 3,800,000 | 0.0% | 3.28% | -6.9% |
| Q1 2021 | $194,826,000 | +51.6% | 3,800,000 | -20.8% | 3.52% | +51.6% |
| Q4 2020 | $128,544,000 | -22.0% | 4,800,000 | 0.0% | 2.32% | -12.0% |
| Q3 2020 | $164,784,000 | -16.2% | 4,800,000 | 0.0% | 2.64% | -13.4% |
| Q2 2020 | $196,656,000 | +282.6% | 4,800,000 | +220.0% | 3.05% | +240.2% |
| Q1 2020 | $51,405,000 | – | 1,500,000 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |